ArticleBioinformation2025
Fentanyl versus dexmedetomidine during awake-fibreoptic intubation.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Awake-fiberoptic intubation is considered the gold standard technique for managing an anticipated difficult airway. Therefore, it is of interest to compare and evaluate fentanyl and dexmedetomidine on intubation conditions during awake-fiberoptic intubation. Hence, 90 patients were randomly divided into two groups, namely Group D and Group F, each consisting of 45 individuals. They were given Dexmedetomidine (1 mcg/kg over 10 minutes) and fentanyl (2 mcg/kg over 10 minutes) followed by monitoring and recording using Ramsay sedation scale at every 2 minutes, 5 minutes, 10 minutes and 20 minutes. Parameters like systolic blood pressure, diastolic blood pressure and heart rate were noted. They found that, the differences are not statistically significant as time advances following intubation, even though dexmedetomidine contributes to the maintenance of a lower systolic blood pressure. Further, the efficacy of dexmedetomidine in reducing diastolic blood pressure is more pronounced; however, following intubation, the disparities between the two groups diminish and it is not statistically significant. Thus, in comparison to fentanyl, dexmedetomidine demonstrates superior efficacy in the management of heart rate both during and immediately following intubation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.